Molecular Analysis of Acquired Tamoxifen Resistance in Breast Cancer Cell Line
Tamoxifen is an FDA approved drug for the prevention and the treatment of breast cancer, but its therapeutic benefit is limited by the development of drug resistance. Many Studies suggest that a basic biological difference exists between tumors with acquired tamoxifen resistance and those with intri...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
West Asia Organization for Cancer Prevention
2017-07-01
|
| Series: | Asian Pacific Journal of Cancer Biology |
| Online Access: | http://www.waocp.org/journal/index.php/apjcb/article/view/36 |